The research progress of LncRNA involved in the regulation of inflammatory diseases

被引：84
|
作者：
Liao, Kaili [1 ,3 ]
Xu, Jiasheng [2 ]
Yang, Weiming [1 ,3 ]
You, Xiahong [1 ,3 ]
Zhong, Qionghui [1 ,3 ]
Wang, Xiaozhong [1 ,3 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Vasc Surg, Nanchang, Jiangxi, Peoples R China
[3] Jiangxi Prov Key Lab Lab Med, Nanchang, Jiangxi, Peoples R China
来源：
MOLECULAR IMMUNOLOGY | 2018年 / 101卷
关键词：
Inflammatory disease; Long non-coding RNA; Inflammation; Inflammatory bowel diseases; LONG NONCODING RNA; DOWN-REGULATION; SMOOTH-MUSCLE; EXPRESSION; APOPTOSIS; TRANSCRIPTION; OVEREXPRESSION; LANDSCAPE; BARRIER; PROFILE;
D O I：
10.1016/j.molimm.2018.05.030
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Long non-coding RNA (IncRNA)is a non-coding RNA which lacks a complete open reading frame(ORF) and plays an important role in biological processes such as cell proliferation,differentiation and apoptosis. At present,the expression of IncRNA has been found to be abnormal in inflammatory reaction and inflammatory diseases. It might be involved in the development and progression of inflammatory diseases by regulating the expression of multiple genes and activation of signaling pathways. This article overviewed the progress in study on relationship between lncRNA and inflammatory diseases.
引用
收藏
页码：182 / 188
页数：7
相关论文
共 50 条
  • [21] Divergent regulation of lncRNA expression by ischemia in adult and aging mice
    Kaucsar, Tamas
    Roka, Beata
    Tod, Pal
    Do, Phuong Thanh
    Szenasi, Gabor
    Hamar, Peter
    Hegediis, Zoltan
    GEROSCIENCE, 2022, 44 (01) : 429 - 445
  • [22] Epigenetic and lncRNA regulation of cardiac pathophysiology
    Chang, Ching-Pin
    Han, Pei
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1767 - 1771
  • [23] Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)
    Wu, Kailiang
    Niu, Chen
    Liu, Hanjiao
    Fu, Li
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 62 (05)
  • [24] Bioinformatics tools for lncRNA research
    Iwakiri, Junichi
    Hamada, Michiaki
    Asai, Kiyoshi
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2016, 1859 (01): : 23 - 30
  • [25] Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer
    Zheng, Zhaodi
    Li, Guorong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [26] The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases
    Huang, Ying
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) : 5768 - 5775
  • [27] lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
    Jin, Huan
    Du, Wei
    Huang, Wentao
    Yan, Jiajing
    Tang, Qing
    Chen, Yibing
    Zou, Zhengzhi
    MOLECULAR THERAPY NUCLEIC ACIDS, 2021, 25 : 613 - 637
  • [28] LncRNA: a new perspective on the study of neurological diseases
    Ma, Yun
    He, Siqi
    Gu, Tianhe
    Liu, Yixuan
    He, Shuya
    Jiang, Zhisheng
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, 50 (02) : 951 - 963
  • [29] LncRNA PTPRE-AS1 modulates M2 macrophage activation and inflammatory diseases by epigenetic promotion of PTPRE
    Han, Xiao
    Huang, Saihua
    Xue, Ping
    Fu, Jinrong
    Liu, Lijuan
    Zhang, Caiyan
    Yang, Lan
    Xia, Li
    Sun, Licheng
    Huang, Shau-Ku
    Zhou, Yufeng
    SCIENCE ADVANCES, 2019, 5 (12):
  • [30] LncRNA/CircRNA-miRNA-mRNA Axis in Atherosclerotic Inflammation: Research Progress
    Lv, Nuan
    Zhang, Yilin
    Wang, Luming
    Suo, Yanrong
    Zeng, Wenyun
    Yu, Qun
    Yu, Bin
    Jiang, Xijuan
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (08) : 1021 - 1040
12345